LRCX vs MEDP · P/E 71, rev $23.23B vs P/E 25, rev $707.3M
Lam Research Corp (LRCX) versus Medpace Holdings Inc (MEDP) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Not investment advice. Open the LRCX and MEDP stock pages for the full models.
Not investment advice.